United Therapeutics Corporation logo

United Therapeutics Corporation (UTHR)

Market Closed
9 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
300. 56
+6.14
+2.09%
Pre Market
$
300. 56
0 0%
13.1B Market Cap
11.96 P/E Ratio
0% Div Yield
416,400 Volume
24.04 Eps
$ 294.42
Previous Close
Day Range
295.3 300.91
Year Range
266.98 417.82
Want to track UTHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 19 days
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
29 Jul 2025 (In 2 weeks)
7.35
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
29 Apr 2025
6.66
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
19 Feb 2025
6.27
Cons. EPS
6.19
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
30 Oct 2024
6.43
Cons. EPS
6.39
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
31 Jul 2024
6.4
Cons. EPS
5.85
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
1 May 2024
5.65
Cons. EPS
6.17
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
21 Feb 2024
4.19
Cons. EPS
4.36
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
20 Feb 2024
4.19
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
1 Nov 2023
5.04
Cons. EPS
5.38
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
31 Oct 2023
5.08
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
27 Oct 2016
3.34
Cons. EPS
3.5
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
28 Jul 2016
3.22
Cons. EPS
4.39
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
28 Apr 2016
3.21
Cons. EPS
4.84
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
25 Feb 2016
2.55
Cons. EPS
2.1
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
27 Oct 2015
2.54
Cons. EPS
4.91
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
28 Jul 2015
2.31
Cons. EPS
1.91
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
28 Apr 2015
2.14
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
24 Feb 2015
2.03
Cons. EPS
2.37
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
28 Oct 2014
1.97
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
29 Jul 2014
1.75
Cons. EPS
2.1
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
29 Apr 2014
1.65
Cons. EPS
2.43
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
25 Feb 2014
1.51
Cons. EPS
-
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
29 Oct 2013
1.59
Cons. EPS
1.17
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
25 Jul 2013
1.47
Cons. EPS
1.52
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
25 Apr 2013
1.47
Cons. EPS
1.19
EPS
United Therapeutics Corporation logo
UTHR United Therapeutics Corporation
26 Feb 2013
1.25
Cons. EPS
1.6
EPS

UTHR Earnings Reports FAQ

What is the earnings per share (EPS) for UTHR?

The current EPS is 24.04.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately 13.09%, reflecting the UTHR's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2025-07-29, based on the UTHR's typical earnings announcement schedule.